Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Lubricating Eye Drops

1 clinical trial

2 indications

Indication
Ovarian Cancer
Indication
Folate Receptor-Alpha Positive
Clinical trial
A Randomized Phase 2 Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Patients With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
Status: Not yet recruiting, Estimated PCD: 2026-05-26